Skip to main content
Log in

Ventricular arrhythmias prior to continuous flow left ventricular assist device implantation were not associated with reduced 1-year mortality: a single-center experience

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

AAD:

Anti-arrhythmic drug

ICD:

Implantable cardioverter-defibrillator

CF-LVAD:

Continuous flow left ventricular assist device

RVAD:

Right ventricular assist device

VA:

Ventricular arrhythmias

References

  1. Imamura T, Chung B, Nguyen A, et al. Clinical implications of hemodynamic assessment during left ventricular assist device therapy. J Cardiol. 2018;71(4):352–8. https://doi.org/10.1016/j.jjcc.2017.12.001.

    Article  PubMed  Google Scholar 

  2. Brenyo A, Rao M, Koneru S, et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012;23(5):515–20. https://doi.org/10.1111/j.1540-8167.2011.02223.x.

    Article  PubMed  Google Scholar 

  3. Greet BD, Pujara D, Burkland D, et al. Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices: a 15-year institutional experience. JACC EP. 2018;4(2):257–64. https://doi.org/10.1016/j.jacep.2017.11.001.

    Article  Google Scholar 

  4. Gopinathannair R, Pothineni NVK, Trivedi JR, et al. Amiodarone use and all-cause mortality in patients with a continuous-flow left ventricular assist device. J Am Heart Assoc. 2022;11(11): e023762. https://doi.org/10.1161/JAHA.121.023762.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kushnir A, Pallister KH, Chaudhary SB, et al. High-density substrate and activation mapping of epicardial ventricular tachycardia during left ventricular assist device implant. HeartRhythm Case Rep. 2020;6(10):690–3. https://doi.org/10.1016/j.hrcr.2020.06.023.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Moss JD, Oesterle A, Raiman M, et al. Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation. J Cardiovasc Electrophysiol. 2019;30(2):183–92. https://doi.org/10.1111/jce.13803.

    Article  PubMed  Google Scholar 

  7. Patel M, Rojas F, Shabari FR, et al. Safety and feasibility of open chest epicardial mapping and ablation of ventricular tachycardia during the period of left ventricular assist device implantation. J Cardiovasc Electrophysiol. 2016;27(1):95–101. https://doi.org/10.1111/jce.12839.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nilesh Mathuria.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pandat, S., Rothstein, P., Laird, R. et al. Ventricular arrhythmias prior to continuous flow left ventricular assist device implantation were not associated with reduced 1-year mortality: a single-center experience. J Interv Card Electrophysiol (2023). https://doi.org/10.1007/s10840-023-01698-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10840-023-01698-3

Navigation